Atopic Dermatitis Treatment Market2017-2022: Market is Anticipated to Expand at a Significant CAGR of 13%.
Atopic Dermatitis Treatment Market By Treatment Type (Drug Treatment, Radiation Treatment), By Route Of Administration (Topical, Oral)
(EMAILWIRE.COM, January 24, 2018 ) The Global Atopic Dermatitis Treatment market size was around USD 7.23 billion in 2017. It is expected to grow at a CAGR of 13% to reach USD 13.32 billion by 2022.
Atopic Dermatitis is a inflammatory skin disease. The degree of its severity varies from patient to patient. It usually begins in childhood and is mostly confined to the flexural surfaces of the body. It is highly prevalent. It is more commonly known as eczema. Itching, redness of skin, cracking, weeping etc. are symptoms of it. It is a long term disease. Low humidity, cold weather, seasonal allergies are the common causes of it. Pattern of the disease and its severity determine the kind of treatment it ought to receive.
View Full Report: https://www.marketdataforecast.com/market-reports/atopic-dermatitis-treatment-market-5354/
Growing patient population, a lot of new product launches, climate change, and large pipeline products are the primary drivers of market growth.
Very strict regulations and generic competition are the primary restraints of market growth.
The market is categorized by route of administration, treatment type, and by distribution channel. If we go by treatment type the market is segregated into Drug treatment and Radiation treatment. Drug treatment is further sub-categorized into corticosteroids, emollients, antihistamines, calcineurin inhibitors and antibiotics. Corticosteroids capture the largest market share and are expected to retain their lead till the end of 2022. Classification by Route of administration is done into topical and oral. Topical leads the market and is likely to retain its lead in the aforementioned forecast period. Oral medicines are for patients with severe cases. Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies is the classification based on the distribution channels.
Request for Sample: https://www.marketdataforecast.com/market-reports/atopic-dermatitis-treatment-market-5354/request-sample
By geography the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East and Africa. North America is the market leader. New product launches, early treatment adoption and lifestyle changes are the reasons behind it. Europe is the second largest market. Heavy investment in R&D activities in this region is the cause for the observable trend mentioned above. Asia Pacific is predicted to be the fastest growing market in the aforementioned forecast period. Rapidly growing population, changing lifestyles and a paradigm shift towards western lifestyles, increasing R&D, and large target patient pool are the reasons attributable to the observable trend mentioned above. Latin America and MEA regions are anticipated to undergo sluggish growth in the aforementioned forecast period.
Inquiry before buying: https://www.marketdataforecast.com/market-reports/atopic-dermatitis-treatment-market-5354/inquire
Key players in the market are Astellas Pharma Inc., Valeant Pharmaceuticals International, Inc., and Sanofi S.A. Other players in the market include Anacor Pharmaceuticals, Inc. Meda Pharmaceuticals, Regeneron Pharmaceuticals Inc., and Novartis International AG, Pfizer Inc.
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
Atopic Dermatitis is a inflammatory skin disease. The degree of its severity varies from patient to patient. It usually begins in childhood and is mostly confined to the flexural surfaces of the body. It is highly prevalent. It is more commonly known as eczema. Itching, redness of skin, cracking, weeping etc. are symptoms of it. It is a long term disease. Low humidity, cold weather, seasonal allergies are the common causes of it. Pattern of the disease and its severity determine the kind of treatment it ought to receive.
View Full Report: https://www.marketdataforecast.com/market-reports/atopic-dermatitis-treatment-market-5354/
Growing patient population, a lot of new product launches, climate change, and large pipeline products are the primary drivers of market growth.
Very strict regulations and generic competition are the primary restraints of market growth.
The market is categorized by route of administration, treatment type, and by distribution channel. If we go by treatment type the market is segregated into Drug treatment and Radiation treatment. Drug treatment is further sub-categorized into corticosteroids, emollients, antihistamines, calcineurin inhibitors and antibiotics. Corticosteroids capture the largest market share and are expected to retain their lead till the end of 2022. Classification by Route of administration is done into topical and oral. Topical leads the market and is likely to retain its lead in the aforementioned forecast period. Oral medicines are for patients with severe cases. Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies is the classification based on the distribution channels.
Request for Sample: https://www.marketdataforecast.com/market-reports/atopic-dermatitis-treatment-market-5354/request-sample
By geography the market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East and Africa. North America is the market leader. New product launches, early treatment adoption and lifestyle changes are the reasons behind it. Europe is the second largest market. Heavy investment in R&D activities in this region is the cause for the observable trend mentioned above. Asia Pacific is predicted to be the fastest growing market in the aforementioned forecast period. Rapidly growing population, changing lifestyles and a paradigm shift towards western lifestyles, increasing R&D, and large target patient pool are the reasons attributable to the observable trend mentioned above. Latin America and MEA regions are anticipated to undergo sluggish growth in the aforementioned forecast period.
Inquiry before buying: https://www.marketdataforecast.com/market-reports/atopic-dermatitis-treatment-market-5354/inquire
Key players in the market are Astellas Pharma Inc., Valeant Pharmaceuticals International, Inc., and Sanofi S.A. Other players in the market include Anacor Pharmaceuticals, Inc. Meda Pharmaceuticals, Regeneron Pharmaceuticals Inc., and Novartis International AG, Pfizer Inc.
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results